Genopathy
Gene-Disorder Association · Article
Gene
GCLM
Glutamate-Cysteine Ligase Modifier Subunit
Manually curated
Association Review

In brief

The association between GCLM (Glutamate-Cysteine Ligase Modifier Subunit) and Myocardial Infarction is well established and manually curated, with its 4 contributing sources — 2 of them expert-curated — recording a known molecular basis and a susceptibility locus.

Sources 4
Clinical variants 1
Symptoms 3
Compounds 0
Trials 0
Publications 3
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

4 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
GCLM

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Myocardial Infarction

The disorder

11 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

1 clinical variant

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Genomic context

Regulatory context

1 regulatory element

GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.

Request access
07
Literature

Reading

3 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

10 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access